As we kick-off 2024, we want to know—What are the challenges you face with your clinical trial technology? Is your eCOA platform delivering the highest quality data? Is your IRT built to handle protocol amendments quickly? Are your sites still struggling with paper consent?

A pharma company came to us recently with a major concern. Their incumbent IRT platform took more than 6 weeks for each (of the 8!) protocol amendments during their trial. The 48+ weeks in trial delays was unacceptable.

At YPrime, our platform helps you do better. From eConsent and eCOA, to IRT, we empower you to solve for certainty in clinical research. FIll out the form, and one of our experts will be in touch today.